Evidence map›Paper›PMID 33949430›Full record

ArticleThe Analyst2021

High spatial-resolution imaging of label-free

Li-En Lin, Kun Miao, Chenxi Qian, Lu Wei

Abstract read
In one paragraph

Article in The Analyst, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. GFP-free live neuron quantitative imaging reveals compartmentalization and growth dynamics of polyQ aggregates.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Toward the Next Frontiers of Vibrational Bioimaging.Chemical & biomedical imaging · 2023
    Review
  9. Article
  10. Super-Resolution Vibrational Imaging Using Expansion Stimulated Raman Scattering Microscopy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  11. Label-Free Super-Resolution Imaging Techniques.Annual review of analytical chemistry (Palo Alto, Calif.) · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Li-En LinDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA. lwei@caltech.edu.
Kun Miao
Chenxi Qian
Lu Wei

Funding

Super-resolution Chemical Imaging for BiomedicineDP2GM140919 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI WEI, LU · 2020 to 2020
$2.3M
NIGMS NIH HHS DP2 GM140919
6 · The paper itself

Abstract

Amyloid aggregation, formed by aberrant proteins, is a pathological hallmark for neurodegenerative diseases, including Alzheimer's disease and Huntington's disease. High-resolution holistic mapping of the fine structures from these aggregates should facilitate our understanding of their pathological roles. Here, we achieved label-free high-resolution imaging of the polyQ and the amyloid-beta (Aβ) aggregates in cells and tissues utilizing a sample-expansion stimulated Raman strategy. We further focused on characterizing the Aβ plaques in 5XFAD mouse brain tissues. 3D volumetric imaging enabled visualization of the whole plaques, resolving both the fine protein filaments and the surrounding components. Coupling our expanded label-free Raman imaging with machine learning, we obtained specific segmentation of aggregate cores, peripheral filaments together with cell nuclei and blood vessels by pre-trained convolutional neural network models. Combining with 2-channel fluorescence imaging, we achieved a 6-color holistic view of the same sample. This ability for precise and multiplex high-resolution imaging of the protein aggregates and their micro-environment without the requirement of labeling would open new biomedical applications.

Indexed as

Alzheimer DiseaseProtein AggregatesAmyloidAmyloid beta-PeptidesAnimalsMicePlaque, AmyloidAmyloidAmyloid beta-PeptidesProtein Aggregates

Identifiers

PMID33949430
PMCPMC8238904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.